Seqens Seqens

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Digital content for Shionogi

    Client Virtual Booth

    SHIONOGI

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    DOSSIERs // Finished Dosage Formulations

    EXCIPIENTS

    PharmaCompass
    Contact SupplierContact Supplier
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Send me more info on How To Grow My Bussiness Digitally?
    Shionogi
    japan Flag
    Country
    Country
    Japan
    Address
    Address
    1-8, Doshomachi 3-chome, Chuo-ku, Osaka 541-0045
    Telephone
    Telephone
    +81-6-6202-2161
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.shionogi.com/eu/en/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/shionogi-inc-/?originalSubdomain=in
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Full View ScreenFull Screen View
    ESCMID 2024: Shionogi Presents Fetcroja Real-World Efficacy Data
    ESCMID 2024: Shionogi Presents Fetcroja Real-World Efficacy Data

    https://www.businesswire.com/news/home/20240418017364/en

    BUSINESSWIRE
    18 Apr 2024
    Share Share
    Taiwan FDA approves Shionogi's FETROJA
    Taiwan FDA approves Shionogi's FETROJA

    https://www.biospectrumasia.com/news/25/23823/taiwan-fda-approves-shionogis-fetroja-for-treating-complicated-urinary-tract-infections.html

    BIOSPECTRUM ASIA
    28 Feb 2024
    Share Share
    Akili Announces Positive Results from Shionogi’s Phase 3 Trial of EndeavorRx
    Akili Announces Positive Results from Shionogi’s Phase 3 Trial of EndeavorRx

    https://www.businesswire.com/news/home/20240226611094/en

    BUSINESSWIRE
    27 Feb 2024
    Share Share
    Akili Announces Results from Phase 3 Trial of Localized Version of EndeavorRx
    Akili Announces Results from Phase 3 Trial of Localized Version of EndeavorRx

    https://www.businesswire.com/news/home/20240222202566/en

    BUSINESSWIRE
    26 Feb 2024
    Share Share
    Shionogi Announces Phase 3 Data Showing Early Resolution of COVID-19 Symptoms
    Shionogi Announces Phase 3 Data Showing Early Resolution of COVID-19 Symptoms

    https://www.businesswire.com/news/home/20240209150579/en

    BUSINESSWIRE
    09 Feb 2024
    Share Share
    Shionogi brings generative AI to conferences with 'Warrior' portrait campaign
    Shionogi brings generative AI to conferences with 'Warrior' portrait campaign

    https://endpts.com/shionogi-brings-generative-ai-to-medical-conferences-with-warrior-portrait-campaign/

    Beth Snyder Bulik ENDPTS
    27 Nov 2023
    Share Share
    Japan's Shionogi establishes JV with US-based Apnimed to treat sleep disorders
    Japan's Shionogi establishes JV with US-based Apnimed to treat sleep disorders

    https://www.biospectrumasia.com/news/25/23261/japans-shionogi-establishes-jv-with-us-based-apnimed-to-treat-sleep-disorders.html

    BIOSPECTRUM ASIA
    03 Nov 2023
    Share Share
    Apnimed Announces Launch of Joint Venture with Shionogi
    Apnimed Announces Launch of Joint Venture with Shionogi

    https://www.globenewswire.com//news-release/2023/11/01/2770728/0/en/Apnimed-Announces-Launch-of-Joint-Venture-with-Shionogi-to-Develop-Novel-Pharmacologic-Therapies-for-Obstructive-Sleep-Apnea-and-other-Sleep-Disorders.html

    GLOBENEWSWIRE
    31 Oct 2023
    Share Share
    F2G and Shionogi Present Full Data Set from Pivotal Phase 2b Study at TIMM
    F2G and Shionogi Present Full Data Set from Pivotal Phase 2b Study at TIMM

    https://www.globenewswire.com//news-release/2023/10/21/2764291/0/en/F2G-and-Shionogi-Present-Full-Data-Set-from-Pivotal-Phase-2b-Study-at-Trends-in-Medical-Mycology-TIMM-2023-Demonstrating-Positive-Therapeutic-Responses-in-Patients-with-Invasive-Fu.html

    GLOBENEWSWIRE
    21 Oct 2023
    Share Share
    Shionogi Presents Evidence Demonstrating Effectiveness of Fetroja
    Shionogi Presents Evidence Demonstrating Effectiveness of Fetroja

    https://www.businesswire.com/news/home/20231010481450/en

    BUSINESSWIRE
    11 Oct 2023
    Share Share
    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    veranova-m-2024-04-22

    Access Virtual Booth

    Contact Supplier

    Send me more info on How To Grow My Business Digitally?
    Post Enquiry
    POST ENQUIRY

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search